Cristina Ana Mocanu
Overview
Explore the profile of Cristina Ana Mocanu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Voicu G, Mocanu C, Safciuc F, Rebleanu D, Anghelache M, Cecoltan S, et al.
Int J Biol Macromol
. 2024 Oct;
281(Pt 1):136355.
PMID: 39374726
Endothelial to mesenchymal transition (EndMT) of valvular endothelial cells (VEC) is a key process in the development and progression of calcific aortic valve disease (CAVD). High expression of the Smad3...
2.
Voicu G, Mocanu C, Safciuc F, Anghelache M, Deleanu M, Cecoltan S, et al.
Mater Today Bio
. 2023 Apr;
20:100620.
PMID: 37063777
Runx2 is a key transcription factor involved in valvular interstitial cells (VIC) osteodifferentiation, a process actively entwined with the calcific aortic valve disease (CAVD). We hypothesize that a strategy intended...
3.
Filippi A, Constantin A, Alexandru N, Mocanu C, Vlad M, Fenyo I, et al.
Pharmaceutics
. 2022 May;
14(5).
PMID: 35631662
The number and function of endothelial progenitor cells (EPCs) are reduced in diabetes, contributing to deteriorated vascular repair and the occurrence of cardiovascular complications. Here, we present the results of...
4.
Voicu G, Rebleanu D, Mocanu C, Tanko G, Droc I, Uritu C, et al.
Int J Mol Sci
. 2022 Apr;
23(7).
PMID: 35409184
Calcific aortic valve disease (CAVD) is a progressive inflammatory disorder characterized by extracellular matrix remodeling and valvular interstitial cells (VIC) osteodifferentiation leading to valve leaflets calcification and impairment movement. Runx2,...
5.
Mocanu C, Fuior E, Voicu G, Rebleanu D, Safciuc F, Deleanu M, et al.
J Control Release
. 2021 Sep;
338:754-772.
PMID: 34530051
The receptor for advanced glycation end products (RAGE) plays a central role in the chronic inflammatory process associated with atherosclerosis development. We aimed to develop lipoplexes carrying RAGE-short hairpin (sh)...
6.
Fuior E, Mocanu C, Deleanu M, Voicu G, Anghelache M, Rebleanu D, et al.
Pharmaceutics
. 2020 Nov;
12(11).
PMID: 33182380
Naringenin, an anti-inflammatory citrus flavonoid, is restrained from large-scale use by its reduced water solubility and bioavailability. To overcome these limitations, naringenin was loaded into lipid nanoemulsions directed towards vascular...